Non-Squamous Non-Small Cell Lung Cancer Withdrawn Phase 1 Trials for Paclitaxel (DB01229)

Also known as: Non-squamous Non-small Cell Lung Cancer

IndicationStatusPhase
DBCOND0036730 (Non-Squamous Non-Small Cell Lung Cancer)Withdrawn1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01702714A Study of RO5083945 in Combination With Cisplatin and Gemcitabine or Carboplatin and Paclitaxel in Patients With Advanced or Recurrent Non-Small Cell Lung Cancer of Squamous Histology Who Have Not Received Prior Chemotherapy for The Metastatic DiseaseTreatment